[email protected] ). 13 9 2007 13 11 2007 19 12 2007 19 12 2007 © The Authors Journal compilation © 2008 Biochemical Society 2008 apolipoprotein A-1 atherosclerosis autoantibody coronary disease oxidized low-density lipoprotein stroke ApoA-1 (apolipoprotein A-1...

... The Biochemical Society 2007 atherosclerosis coronary disease hypoxia/anoxia myocardial infarction natriuretic peptide oxygen-regulated protein 150 (ORP150) The prognosis following AMI (acute myocardial infarction) varies widely, and recent evidence suggests that biochemical markers may...

... for the present study based on the expectation of a 4–5% improvement in FMD with dietary intervention [ 16 ]. Our sample size calculation indicated that between 16 and 20 subjects would be required in each treatment arm to detect a difference at a P value <0.01 with 90% power. blood flow coronary...

... 2005 25 11 2005 25 11 2005 The Biochemical Society 2006 coronary disease endothelial function fibrinolysis inflammation tumour necrosis factor-α (TNF-α) vasodilation In epidemiologic studies of patients with CHD (coronary heart disease) [ 1 ] and in prospective...

... effects on the interaction between platelets and neutrophils. Correspondence: Professor Nen-Chung Chang (email [email protected] ). 31 1 2005 8 4 2005 18 5 2005 18 5 2005 The Biochemical Society 2005 angioplasty coronary disease inflammation ion channels...

.... The present study demonstrates that elevated QTVI in patients with CRF is associated with diabetes and coronary disease. The present findings are important given that repolarization instability may predispose to ventricular arrhythmia and sudden death, events that occur frequently in CRF patients. Numerical...

... 11 2002 31 1 2003 26 2 2003 26 2 2003 © 2003 The Biochemical Society 2003 atherosclerosis cell adhesion molecules cardiovascular disease coronary disease ethnicity Clinical Science (2003) 104, 591 598 (Printed in Great Britain) 591 Ethnic differences in circulating...

... to that from animal or cell culture models of drug-eluting stents. coronary disease histopathology local drug delivery restenosis smooth muscle The Biochemical Society and the Medical Research Society © 2002 2002 18 1 2002 11 6 2002 Correspondence : Dr N. Swanson (e-mail ns56...

... guidelines for the primary prevention of CHD in Type II diabetes. Correspondence: Dr Richard J. Stevens (e-mail [email protected] ). 18 12 2000 23 5 2001 21 8 2001 coronary disease diabetes mellitus models non-insulin-dependent statistical The Biochemical...

...-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany (e-mail [email protected] ). 26 6 2000 6 9 2000 26 10 2000 The Biochemical Society and the Medical Research Society © 2001 2001 atherosclerosis coronary disease endothelial function nitric oxide ultrasound...

... to the protective effects of β-blockers in patients with coronary disease. 17 12 1997 15 1 1998 © 1998 The Biochemical Society and the Medical Research Society 1998 antioxidants β-blockers coronary disease high-density lipoprotein low-density lipoprotein oxidation Clinical Science...

...-hypertensive agents cerebrovascular disorders coronary disease hypertension morbidity mortality Clinical Science and Molecular Medicine (1976) 51,645s-647~. Report on progress in the Australian National Blood Pressure Study (NBPS) J. D. A B E R N E T H Y , J . L. B A K E R , M. U . B U L L E N , M . L...